Mastocalcergy in the mouse.
D000085:Acetates / Q000008:administration & dosage; D000818:Animals; D002114:Calcinosis / Q000139:chemically induced*; D002130:Calcium Phosphates; D002196:Capillaries; D002199:Capillary Permeability; D002807:Chondroitin; D003404:Creatinine; D003594:Cytoplasmic Granules; D006493:Heparin; D006632:Histamine / Q000009:adverse effects; D006651:Histocytochemistry; D006820:Hyaluronic Acid; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007854:Lead / Q000008:administration & dosage*; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D051379:Mice; D010539:Permeability; D010710:Phosphates; D011113:Polymyxins / Q000009:adverse effects*; D012701:Serotonin / Q000009:adverse effects; D013431:Sulfates; D014665:Vasodilator Agents
D000085:Acetates; D002130:Calcium Phosphates; D010710:Phosphates; D011113:Polymyxins; D013431:Sulfates; D014665:Vasodilator Agents; D007854:Lead; D012701:Serotonin; D006632:Histamine; D006820:Hyaluronic Acid; D006493:Heparin; D002807:Chondroitin; D003404:Creatinine